1. Market Research
  2. > Healthcare Market Trends
  3. > Presence Health - Strategic SWOT Analysis Review

Presence Health - Strategic SWOT Analysis Review

  • February 2017
  • -
  • GlobalData
  • -
  • 25 pages

Presence Health - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Presence Health (Presence) is a non-profit catholic health care system that provides comprehensive health care services. Presence consists of acute care hospitals, nursing homes, rehabilitation centers, and senior living care facilities, which provide a full range of inpatient and outpatient medical services. Its portfolio of services include behavioral health, cancer care, cardiovascular care, tele-ICU, emergency care, imaging, critical care, infoline, neuroscience, occupational health, orthopedics and sports medicine, senior services, and surgery. Its hospitals are designated as Primary Stroke Centers. The organization also provides financial assistance and insurance plans. Presence was formed as a merger of Provena Health and Resurrection Health Care. Presence Health is headquartered in Chicago, Illinois, the US.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Table Of Contents

Presence Health - Strategic SWOT Analysis Review
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Section 1 - About the Company 5
Presence Health - Key Facts 5
Presence Health - Key Employees 6
Presence Health - Major Products and Services 7
Presence Health - History 11
Presence Health - Company Statement 13
Presence Health - Locations And Subsidiaries 14
Head Office 14
Other Locations and Subsidiaries 14
Section 2 - Company Analysis 16
Presence Health - Business Description 16
Presence Health - SWOT Analysis 17
SWOT Analysis - Overview 17
Presence Health - Strengths 17
Presence Health - Weaknesses 18
Presence Health - Opportunities 19
Presence Health - Threats 20
Presence Health - Key Competitors 21
Section 3 - Company's Lifesciences Financial Deals and Alliances 22
Presence Health, Pharmaceuticals and Healthcare, Deals By Year, 2011 to YTD 2017 22
Presence Health, Pharmaceuticals and Healthcare, Deals By Type, 2011 to YTD 2017 23
Presence Health, Recent Deals Summary 24
Section 4 - Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Presence Health, Key Facts 5
Presence Health, Key Employees 6
Presence Health, Major Products and Services 7
Presence Health, History 11
Presence Health, Other Locations 14
Presence Health, Key Competitors 21
Presence Health, Pharmaceuticals and Healthcare, Deals By Year, 2011 to YTD 2017 22
Presence Health, Pharmaceuticals and Healthcare, Deals By Type, 2011 to YTD 2017 23
Presence Health, Recent Deals Summary 24

List of Figures
Presence Health, Pharmaceuticals and Healthcare, Deals By Year, 2011 to YTD 2017 22
Presence Health, Pharmaceuticals and Healthcare, Deals by Type, 2011 to YTD 2017 23

Companies Mentioned
Rush System for Health
J. C. Blair Memorial Hospital
Evangelical Community Hospital
Elmhurst Memorial Healthcare
Devereux Foundation
Covenant Ministries of Benevolence
Centra Health Inc
Ann and Robert H Lurie Children's Hospital of Chicago
Alexian Brothers Health System
Advocate Health Care

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Ophthalmology Drug Development Pipeline Review, 2016

Ophthalmology Drug Development Pipeline Review, 2016

  • $ 3995
  • Company report
  • December 2016
  • by GBI Research

Ophthalmology Drug Development Pipeline Review, 2016 Summary Ophthalmology disorders are associated with the eyes and visual system. If left untreated, serious long-term co-morbidities such as diabetes, ...

Diabetes & Obesity Drug Development Pipeline Review, 2016

Diabetes & Obesity Drug Development Pipeline Review, 2016

  • $ 3995
  • Company report
  • December 2016
  • by GBI Research

Diabetes & Obesity Drug Development Pipeline Review, 2016 Summary The diabetes and obesity disease cluster is currently dominated by therapeutics indicated for type 1 diabetes mellitus (T1DM) and type ...

Dermatology Therapeutics Drug Development Pipeline Review, 2016

Dermatology Therapeutics Drug Development Pipeline Review, 2016

  • $ 3995
  • Company report
  • December 2016
  • by GBI Research

Dermatology Therapeutics Drug Development Pipeline Review, 2016 Summary Dermatological conditions are one of the most common types of disorders worldwide, and approximately one-third of the US population ...


ref:plp2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.